[
    [
        {
            "time": "2019-03-13",
            "original_text": "北上资金重回净买入！杠杆资金持续加仓，他们最爱这些股（附名单）",
            "features": {
                "keywords": [
                    "北上资金",
                    "净买入",
                    "杠杆资金",
                    "加仓"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "北上资金重回净买入！杠杆资金持续加仓，他们最爱这些股（附名单）",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-03-13",
            "original_text": "信号！连续4天净卖出结束，北上资金恢复净买入！这些公司重获加仓",
            "features": {
                "keywords": [
                    "北上资金",
                    "净卖出",
                    "净买入",
                    "加仓"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "信号！连续4天净卖出结束，北上资金恢复净买入！这些公司重获加仓",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-03-12",
            "original_text": "公告精选：中国平安上海家化年报出炉；华宝股份大手笔分红",
            "features": {
                "keywords": [
                    "中国平安",
                    "上海家化",
                    "年报",
                    "分红"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "金融",
                    "消费品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "公告精选：中国平安上海家化年报出炉；华宝股份大手笔分红",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-03-12",
            "original_text": "恒瑞医药胃癌药通过仿制药一致性评价 15品种已过评",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "胃癌药",
                    "仿制药",
                    "一致性评价"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒瑞医药胃癌药通过仿制药一致性评价 15品种已过评",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-03-12",
            "original_text": "中国生物制药(1177.HK)：研发管线储备丰富引领公司成长，维持“增持”评级，目标价8.14港元",
            "features": {
                "keywords": [
                    "中国生物制药",
                    "研发管线",
                    "增长",
                    "增持"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "中国生物制药(1177.HK)：研发管线储备丰富引领公司成长，维持“增持”评级，目标价8.14港元",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-03-12",
            "original_text": "医疗保健：首家医药公司正式申请拟科创板上市 荐15股",
            "features": {
                "keywords": [
                    "医疗保健",
                    "科创板",
                    "上市",
                    "推荐股票"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医疗保健：首家医药公司正式申请拟科创板上市 荐15股",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-03-12",
            "original_text": "深度|| 中国生物制药：带量采购落地释放悲观预期，研发管线储备丰富引领公司成长【天风医药】",
            "features": {
                "keywords": [
                    "中国生物制药",
                    "带量采购",
                    "悲观预期",
                    "研发管线"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "深度|| 中国生物制药：带量采购落地释放悲观预期，研发管线储备丰富引领公司成长【天风医药】",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-03-12",
            "original_text": "医药周报2019第10期: 首家医药公司正式申请拟科创板上市, 制度创新带动产业升级",
            "features": {
                "keywords": [
                    "医药周报",
                    "科创板",
                    "制度创新",
                    "产业升级"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药周报2019第10期: 首家医药公司正式申请拟科创板上市, 制度创新带动产业升级",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]